173 related articles for article (PubMed ID: 36382882)
1. Phage-assisted, active site-directed ligand evolution of a potent and selective histone deacetylase 8 inhibitor.
Morse JS; Sheng YJ; Hampton JT; Sylvain LD; Das S; Alugubelli YR; Chen PC; Yang KS; Xu S; Fierke CA; Liu WR
Protein Sci; 2022 Dec; 31(12):e4512. PubMed ID: 36382882
[TBL] [Abstract][Full Text] [Related]
2. An amber obligate active site-directed ligand evolution technique for phage display.
Tharp JM; Hampton JT; Reed CA; Ehnbom A; Chen PC; Morse JS; Kurra Y; Pérez LM; Xu S; Liu WR
Nat Commun; 2020 Mar; 11(1):1392. PubMed ID: 32170178
[TBL] [Abstract][Full Text] [Related]
3. The Construction of a Genetically Encoded, Phage-Displayed Cyclic-Peptide Library.
Chen PC; Liu WR
Methods Mol Biol; 2021; 2355():219-230. PubMed ID: 34386961
[TBL] [Abstract][Full Text] [Related]
4. Active Site Metal Identity Alters Histone Deacetylase 8 Substrate Selectivity: A Potential Novel Regulatory Mechanism.
Castaneda CA; Lopez JE; Joseph CG; Scholle MD; Mrksich M; Fierke CA
Biochemistry; 2017 Oct; 56(42):5663-5670. PubMed ID: 28937750
[TBL] [Abstract][Full Text] [Related]
5. An amber-encoding helper phage for more efficient phage display of noncanonical amino acids.
Hampton JT; Cho CD; Coleman DD; Geng ZZ; Chen PC; Dubey GK; Sylvain LD; Xu S; Liu WR
Nucleic Acids Res; 2023 Jul; 51(13):6566-6577. PubMed ID: 37293959
[TBL] [Abstract][Full Text] [Related]
6. Kinetically selective and potent inhibitors of HDAC8.
Schweipert M; Jänsch N; Sugiarto WO; Meyer-Almes FJ
Biol Chem; 2019 May; 400(6):733-743. PubMed ID: 30521473
[TBL] [Abstract][Full Text] [Related]
7. Thermodynamics of binding of structurally similar ligands to histone deacetylase 8 sheds light on challenges in the rational design of potent and isozyme-selective inhibitors of the enzyme.
Singh RK; Suzuki T; Mandal T; Balsubramanian N; Haldar M; Mueller DJ; Strode JA; Cook G; Mallik S; Srivastava DK
Biochemistry; 2014 Dec; 53(48):7445-58. PubMed ID: 25407689
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor.
Vannini A; Volpari C; Filocamo G; Casavola EC; Brunetti M; Renzoni D; Chakravarty P; Paolini C; De Francesco R; Gallinari P; Steinkühler C; Di Marco S
Proc Natl Acad Sci U S A; 2004 Oct; 101(42):15064-9. PubMed ID: 15477595
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Histone Deacetylase 8 (HDAC8) Selective Inhibition Reveals Specific Active Site Structural and Functional Determinants.
Marek M; Shaik TB; Heimburg T; Chakrabarti A; Lancelot J; Ramos-Morales E; Da Veiga C; Kalinin D; Melesina J; Robaa D; Schmidtkunz K; Suzuki T; Holl R; Ennifar E; Pierce RJ; Jung M; Sippl W; Romier C
J Med Chem; 2018 Nov; 61(22):10000-10016. PubMed ID: 30347148
[TBL] [Abstract][Full Text] [Related]
10. Evolved sequence contexts for highly efficient amber suppression with noncanonical amino acids.
Pott M; Schmidt MJ; Summerer D
ACS Chem Biol; 2014 Dec; 9(12):2815-22. PubMed ID: 25299570
[TBL] [Abstract][Full Text] [Related]
11. Variable active site loop conformations accommodate the binding of macrocyclic largazole analogues to HDAC8.
Decroos C; Clausen DJ; Haines BE; Wiest O; Williams RM; Christianson DW
Biochemistry; 2015 Mar; 54(12):2126-35. PubMed ID: 25793284
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel potential selective HDAC8 inhibitors by combine ligand-based, structure-based virtual screening and in-vitro biological evaluation.
Debnath S; Debnath T; Bhaumik S; Majumdar S; Kalle AM; Aparna V
Sci Rep; 2019 Nov; 9(1):17174. PubMed ID: 31748509
[TBL] [Abstract][Full Text] [Related]
13. Encoding Noncanonical Amino Acids into Phage Displayed Proteins.
Díaz-Perlas C; Escobar-Rosales M; Morgan CW; Oller-Salvia B
Methods Mol Biol; 2023; 2676():117-129. PubMed ID: 37277628
[TBL] [Abstract][Full Text] [Related]
14. Catalytic activity and inhibition of human histone deacetylase 8 is dependent on the identity of the active site metal ion.
Gantt SL; Gattis SG; Fierke CA
Biochemistry; 2006 May; 45(19):6170-8. PubMed ID: 16681389
[TBL] [Abstract][Full Text] [Related]
15. Structure of 'linkerless' hydroxamic acid inhibitor-HDAC8 complex confirms the formation of an isoform-specific subpocket.
Tabackman AA; Frankson R; Marsan ES; Perry K; Cole KE
J Struct Biol; 2016 Sep; 195(3):373-378. PubMed ID: 27374062
[TBL] [Abstract][Full Text] [Related]
16. Design of Potent Panobinostat Histone Deacetylase Inhibitor Derivatives: Molecular Considerations for Enhanced Isozyme Selectivity between HDAC2 and HDAC8.
Stoddard SV; May XA; Rivas F; Dodson K; Vijayan S; Adhika S; Parker K; Watkins DL
Mol Inform; 2019 Mar; 38(3):e1800080. PubMed ID: 30369061
[TBL] [Abstract][Full Text] [Related]
17. An insight into selective and potent inhibition of histone deacetylase 8 through induced-fit docking, pharmacophore modeling and QSAR studies.
Kashyap K; Kakkar R
J Biomol Struct Dyn; 2020 Jan; 38(1):48-65. PubMed ID: 30633630
[TBL] [Abstract][Full Text] [Related]
18. Covalent inhibition of histone deacetylase 8 by 3,4-dihydro-2H-pyrimido[1,2-c][1,3]benzothiazin-6-imine.
Muth M; Jänsch N; Kopranovic A; Krämer A; Wössner N; Jung M; Kirschhöfer F; Brenner-Weiß G; Meyer-Almes FJ
Biochim Biophys Acta Gen Subj; 2019 Mar; 1863(3):577-585. PubMed ID: 30611847
[TBL] [Abstract][Full Text] [Related]
19. Design, Synthesis and Biological Characterization of Histone Deacetylase 8 (HDAC8) Proteolysis Targeting Chimeras (PROTACs) with Anti-Neuroblastoma Activity.
Darwish S; Ghazy E; Heimburg T; Herp D; Zeyen P; Salem-Altintas R; Ridinger J; Robaa D; Schmidtkunz K; Erdmann F; Schmidt M; Romier C; Jung M; Oehme I; Sippl W
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886887
[TBL] [Abstract][Full Text] [Related]
20. Pharmacophore-enabled virtual screening, molecular docking and molecular dynamics studies for identification of potent and selective histone deacetylase 8 inhibitors.
Kashyap K; Kakkar R
Comput Biol Med; 2020 Aug; 123():103850. PubMed ID: 32658783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
